We also show, using both genetic and chemical inhibition, that NAMPT inhibition can increase the effect of olaparib in a number of tumour cell models for a disease of particular unmet therapeutic need, TN breast cancer. The gene discussed is NAMPT; the disease is breast carcinoma.